Bcl-2 antibody (AA 54-103)
Quick Overview for Bcl-2 antibody (AA 54-103) (ABIN6735914)
Target
See all Bcl-2 (BCL2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 54-103
-
Specificity
- Human BCL2 / Bcl-2
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa54-103 of human BCL2 (P10415, NP_000624). Percent identity by BLAST analysis: Human, Chimpanzee (100%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P, WB (0.2 - 1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
-
Alternative Name
- BCL2 / Bcl-2
-
Background
-
Name/Gene ID: BCL2
Family: Apoptosis
Synonyms: BCL2, Apoptosis regulator Bcl-2, B-cell CLL/lymphoma 2, B-cell lymphoma protein 2, Bcl-2, PPP1R50 -
Gene ID
- 596
-
NCBI Accession
- NP_000624
-
UniProt
- P10415
-
Pathways
- MAPK Signaling, PI3K-Akt Signaling, Apoptosis, Caspase Cascade in Apoptosis, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Skeletal Muscle Fiber Development, Autophagy, Smooth Muscle Cell Migration, Negative Regulation of intrinsic apoptotic Signaling
Target
-